Advanced Solid Tumors: GSK5764227 Study

We are testing a new drug, GSK5764227, in people with advanced solid tumors to see how safe it is and how it affects their condition. This study aims to gather important information for future treatments.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Institut Bergonie
Departement d'Oncologie Medicale
Bordeaux, France
Centre Leon Berard
Departement de Cancerologie Medicale
Meyzieu, France
Institut Gustave Roussy
Departement Innovations Therapeutiques et Groupe Oncologie Genito-Urinaire
Villejuif, France

Sponsor: Glaxosmithkline Research & Development Limited
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.